The authors described the progressive shift of the tumor (at his 3rd recurrence) from epithelioid to classic GBM pattern, with loss of MGMT methylation and related intense fluorescence expression after 5-ALA administration [17]. The gene discussed is MGMT; the disease is glioblastoma.